Archives of Dermatological Research

, Volume 304, Issue 6, pp 465–469 | Cite as

Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis

  • Senem Buyukkara Yilmaz
  • Nilüfer Cicek
  • Mesut Coskun
  • Olcay Yegin
  • Erkan Alpsoy
Short Communication


Serum IL-17 levels and IL-17 mRNA expression have been reported to be higher in psoriatic skin than normal skin. There are very limited data in the literature about difference in the levels of this cytokine in various clinical disease subtypes. We aimed to evaluate whether there is a difference in the level of this cytokine according to clinical subtypes of psoriasis. 70 psoriasis patients (30 plaque psoriasis, 20 guttate psoriasis, and 20 pustular psoriasis) and 50 age- and sex-matched healthy volunteers were included in the study. Serum IL-17 levels were determined by ELISA. Skin biopsies obtained from lesions and non-lesional skin area of 12 patients and healthy individuals (n = 5) were analyzed by quantitative PCR (qPCR) to measure the mRNA levels of IL-17. Statistically, the serum IL-17 levels did not exhibit any difference between the patients and control groups. However, analysis of each subgroup revealed that the IL-17 levels were significantly higher in pustular psoriasis group (10.09 ± 12.6 pg/ml) than controls (4.4 ± 4.1 pg/ml) (p = 0.02). In addition, the IL-17 levels of plaque psoriasis patients with PASI score 10 (11.30 ± 6.0 pg/ml) were significantly higher than that of patients with PASI score <10 (3.39 ± 2.6 pg/ml) and controls (p < 0.001). The Pearson correlation analysis showed a positive correlation between the serum IL-17 levels and PASI. Lesional skin samples of psoriasis patients showed significantly higher levels of IL-17 mRNA compared with perilesional skin samples (p = 0.017). Also, in the pustular psoriasis, IL-17 mRNA levels were found to be distinctively high in comparison with other clinical subtypes and healthy controls. Our results indicate that IL-17 and Th17 cells have an important role in pustular psoriasis and severe psoriasis.


Psoriasis Plaque psoriasis Guttate psoriasis Pustular psoriasis IL-17 IL-17 mRNA 



We would like to thank Prof. Ugur Yavuzer for her careful review of the manuscript.


  1. 1.
    Arican O, Aral M, Sasmaz S, Ciragil P (2005) Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediat Inflamm 5:273–279CrossRefGoogle Scholar
  2. 2.
    Chen X, Tan Z, Yue Q, Liu H, Liu Z, Li J (2006) The expression of interleukin-23 (p19/p40) and interleukin-12 (p35/p40) in psoriasis skin. J Huazhong Univ Sci Technol Med Sci 26:750–752PubMedCrossRefGoogle Scholar
  3. 3.
    Ekinci NS, Alpsoy E, Karakas AA, Yilmaz SB, Yegin O (2010) IL-17A has an important role in the acute attacks of Behçet’s disease. J Invest Dermatol 130:2136–2138PubMedCrossRefGoogle Scholar
  4. 4.
    Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR (2007) Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 6:169–175PubMedCrossRefGoogle Scholar
  5. 5.
    Johensen C, Usher PA, Kjellerup RB, Lundsgaard D, Iversen L, Kragballe K (2009) Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol 160:319–324CrossRefGoogle Scholar
  6. 6.
    Kaçar C, Sezer I, Kocabaş H, Cay HF, Cevikol C, Alpsoy E, Alkan Melikoğlu M, Akman A (2010) Sacroiliac joint involvement in psoriasis. Rheumatol Int 30:1263–1266PubMedCrossRefGoogle Scholar
  7. 7.
    Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130:1373–1383PubMedCrossRefGoogle Scholar
  8. 8.
    Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467–476PubMedCrossRefGoogle Scholar
  9. 9.
    Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M, Krueger JG (2004) Increased expression of interleukin-23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125–130PubMedCrossRefGoogle Scholar
  10. 10.
    Li J, Chen X, Liu Z, Yue Q, Liu H (2007) Expression of Th17 cytokines in skin lesions of patients with psoriasis. J Huazhong Univ Sci Technol Med Sci 27:330–332PubMedCrossRefGoogle Scholar
  11. 11.
    Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H (2010) Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 35:645–649PubMedCrossRefGoogle Scholar
  12. 12.
    Yan KX, Fang X, Han L, Zhang ZH, Kang KF, Zheng ZZ, Huang Q (2010) Foxp3+ regulatory T cells and related cytokines differentially expressed in plaque vs. guttate psoriasis vulgaris. Br J Dermatol 163(1):48–56PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Senem Buyukkara Yilmaz
    • 1
  • Nilüfer Cicek
    • 2
  • Mesut Coskun
    • 2
  • Olcay Yegin
    • 2
  • Erkan Alpsoy
    • 1
  1. 1.Department of Dermatology and VenereologyAkdeniz University School of MedicineAntalyaTurkey
  2. 2.Department of Pediatric ImmunologyAkdeniz University School of MedicineAntalyaTurkey

Personalised recommendations